Unusual Trading Activity for Salix Pharmaceuticals Ltd. (SLXP)
Posted on 07/27/2010 by Leo Goldman
NEW YORK (Market Intellisearch) -- SLXP options saw interesting call activity today. A total of 270 put and 1,146 call contracts were traded raising a low Put/Call volume alert. Today's traded Put/Call ratio is 0.24. There were 4.24 calls traded for each put contract.
The ratio skew implies that investors are hedging their positions in anticipation of a stock move. Today’s unusual volume activity confirms that traders are rebalancing their portfolios.
Salix Pharmaceuticals Ltd. closed at $44.64 in the last trading session and opened today at $44.90.
The stock price declined $0.99 (-2.22%) to $43.65 in today's trading session.
SLXP is trading between the range of $43.29 - $45.00.
Volume is 675,293 in relation to the three month average volume of 1,242,560 shares.
The technical momentum Relative Strengh Index indicator shows overbought conditions.
SLXP is trading above the 50 day moving average and higher
than the 200 day moving average. The stock's 52 week low is $11.69 and 52 week high is $44.99.
Disclaimer: The material presented in this commentary is provided for informational purposes only and is based upon information that is
considered to be reliable. Neither Market Intellisearch nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as
such. Neither Market Intellisearch nor its affiliates are responsible for any errors or for results obtained from the use of this information.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial
instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without
notice. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly
consider seeking advice from your own financial or investment adviser.
